Comparison Between Psilocybin (Magic Mushroom) and Escitalopram as an Antidepressant
April 18, 2021
- Psilocybin, also known as magic mushroom, is a compound obtained from certain types of hallucinogenic mushrooms found in Mexico, South America, and some parts of the United States.
- Psilocybin may have antidepressant properties however, comparisons between psilocybin and known treatments for depression are lacking.
- In patients with moderate-to-severe major depressive disorder, researchers compared psilocybin with escitalopram.
- Escitalopram is an antidepressant in a group of drugs called selective serotonin reuptake inhibitors.
- Total number of patients enrolled: 59
- Patients assigned to psilocybin group: 30
- Patients assigned to escitalopram group: 29
- All patients received psychological support.
- The results suggest that psilocybin and escitalopram did not show a significant difference in antidepressant effects.
- Secondary outcomes usually favored psilocybin compared with escitalopram however, these analyses lacked correction for multiple comparisons.
- To compare psilocybin with known antidepressants, larger and longer trials are needed.
Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021 Apr 15;384(15):1402-1411. doi: 10.1056/NEJMoa2032994. PMID: 33852780.